Related Experiment Videos
Elevated endothelin-1 plasma concentration in patients with essential hypertension
A Januszewicz1, M Lapiński, B Symonides
1Department of Hypertension and Angiology, Academy of Medicine, Warsaw, Poland.
Journal of Cardiovascular Risk
|June 1, 1994
Summary
Elevated levels of Endothelin-1 (ET-1) and neuropeptide Y are found in patients with essential hypertension. These findings suggest ET-1 plays a role in maintaining high blood pressure.
Area of Science:
- Cardiovascular Research
- Endocrinology
- Hypertension Studies
Background:
- Endothelin-1 (ET-1) is implicated in the development and maintenance of hypertension.
- ET-1 plasma concentrations are elevated or unchanged in essential hypertension patients.
- Investigating ET-1's relationship with other vasoactive substances is crucial.
Purpose of the Study:
- To assess ET-1 plasma concentration in mild-to-moderate essential hypertension.
- To examine the interrelationship between ET-1, catecholamines, neuropeptide Y, and atrial natriuretic peptide (ANP).
Main Methods:
- Radioimmunoassay for ET-1, neuropeptide Y, and ANP.
- Radioenzymatic assay for catecholamines.
- Study included 37 essential hypertension patients and 21 healthy controls.
Main Results:
- Plasma ET-1 and neuropeptide Y levels were significantly elevated in hypertensive patients compared to controls.
- No correlation was observed between plasma ET-1 and neuropeptide Y, catecholamines, or ANP in either group.
Conclusions:
- The results indicate that ET-1 is relevant in the development and maintenance of elevated blood pressure.
- Further research into ET-1's role in hypertension is warranted.